- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07250243
Turkish Validation and Reliability of the John Hopkins In-Room Independence Scale
February 25, 2026 updated by: Selda Çiftci, Sisli Hamidiye Etfal Training and Research Hospital
Turkish Validity and Reliability Study of the John Hopkins In-Room Independence Scale: A Cross-Sectional Diagnostic Value Study
The aim was to conduct a Turkish validity and reliability study of the Johns Hopkins In-Room Independence Scale.
The investigators believe this scale will address the lack of information regarding fall risk and dependency, particularly for patients scheduled for discharge and their caregivers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Independence and fall risk are critical for many illnesses and age groups.
Patients receiving inpatient physical therapy in a Physical Medicine and Rehabilitation clinic often worry about returning home and performing daily activities after discharge.
Therefore, this scale assessing in-room independence will allow clinicians to better warn and guide patients about potential risks.
Study Type
Observational
Enrollment (Actual)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey (Türkiye)
- Sisli Hamidiye Etfal Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients aged 18 and over who are receiving inpatient treatment in the PM&R service with any diagnosis
Description
Inclusion Criteria:
- Ages 18 and over
- Volunteering to participate in the study
Exclusion Criteria:
- Patients <18 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients receiving treatment in a physical medicine and rehabilitation inpatient clinic
Patients aged 18 and over who are receiving inpatient treatment at the PM&R inpatient clinic with any diagnosis
|
The Turkish validity and reliability study of The Johns Hopkins Hospital In-Room Independence Scale(JH-IRIS) will be conducted.The researchers who developed the scale were contacted and a two-stage translation was conducted based on their suggestions.The final Turkish version of the scale was agreed upon after an online meeting with the developing research group.Because the other scales used in the original study lacked Turkish validity, the decision was made to use the Turkish-validated Morse and Henrich-2 Fall Scales and the Barthel Index, with the research team's permission.The study planned to include patients hospitalized for rehabilitation over a four-month period, regardless of their indication.This will allow comparison with previously validated Turkish fall risk and independence scales.One week later, patients will complete the JH-IRIS again and undergo a test-retest.The scale will be evaluated by two different researchers to determine inter-observer reliability.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Johns Hopkins Hospital In-Room Independence Scale
Time Frame: 1 week
|
The Johns Hopkins Hospital In-Room Independence Scale is a scale that assesses a person's in-room independence, assessing mobility, toileting, and cognition.
It consists of 15 items.
A person who passes all items receives a score of 15.
Failure on any item indicates in-room dependency.
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Morse Fall Scale
Time Frame: 1 week
|
The Morse Fall Scale is an 125-point assessment tool that evaluates the risk of falling by considering factors such as fall history, secondary diagnoses, need for a walking aid, gait and transfer, and mental status; higher scores indicate poorer functioning.
|
1 week
|
|
Hendrich II Fall Risk Scale
Time Frame: 1 week
|
The Hendrich II Fall Risk Scale assesses patients' fall risk.
The scale includes factors like confusion, depression, dizziness, male gender, certain medications, and a mobility test.
A score of 5 or above indicates high risk.
|
1 week
|
|
Barthel Index
Time Frame: 1 week
|
The Barthel Index is an evaluation tool used to measure independence in performing 10 physical activities of daily living, with a primary focus on self-care and mobility.
Minimum: 0,.
Maximum: 100 (higher is better).
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Banu Kuran, Professor, Sisli Hamidiye Etfal Training and Research Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2025
Primary Completion (Actual)
January 1, 2026
Study Completion (Actual)
January 15, 2026
Study Registration Dates
First Submitted
November 18, 2025
First Submitted That Met QC Criteria
November 18, 2025
First Posted (Actual)
November 26, 2025
Study Record Updates
Last Update Posted (Actual)
February 27, 2026
Last Update Submitted That Met QC Criteria
February 25, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Synucleinopathies
- Neurologic Manifestations
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neuromuscular Diseases
- Arthritis
- Joint Diseases
- Rheumatic Diseases
- Peripheral Nervous System Diseases
- Neurodegenerative Diseases
- Movement Disorders
- Parkinsonian Disorders
- Basal Ganglia Diseases
- Paralysis
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Osteoarthritis
- Polyneuropathies
- Parkinson Disease
- Musculoskeletal Diseases
- Paraplegia
- Hemiplegia
Other Study ID Numbers
- 08.19.2025/approval no: 5022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on In-room independence assessment
-
Atılım UniversityCompleted
-
Centro Hospitalar do PortoUnknownActivities of Daily Living | Hospitalization | Nursing Care | Functional ImpairmentPortugal
-
University of Alabama at BirminghamNational Institute on Aging (NIA)Completed
-
Ain Shams Maternity HospitalCompletedEarly Discharge of Patients After Cesarean SectionEgypt
-
University of BrasiliaRecruitingHealth Education | Arrythmia | Escape-RoomBrazil
-
VA Office of Research and DevelopmentRecruitingFunctional IndependenceUnited States
-
St. Justine's HospitalUnknownSimulation | Neonatal Resuscitation
-
Vejle HospitalCompleted
-
University of Southern CaliforniaRecruiting
-
Karadeniz Technical UniversityActive, not recruitingDental AnxietyTurkey (Türkiye)